Global Non opioid Pain Patches Market Research Report 2025(Status and Outlook)
Description
Report Overview
Non-opioid pain patches are transdermal therapeutic systems designed to deliver analgesic medications—such as lidocaine, diclofenac, capsaicin, or methyl salicylate—through the skin to provide localized or systemic pain relief without the risks associated with opioid use, including addiction and systemic side effects. These patches are widely used for chronic pain conditions like arthritis, neuropathy, and musculoskeletal injuries, offering controlled drug release for extended periods while minimizing gastrointestinal and hepatic side effects common with oral analgesics. The market has expanded due to rising opioid misuse concerns, an aging population with higher pain management needs, and increasing preference for non-invasive, targeted drug delivery. Innovation in patch formulations—such as combination therapies and longer wear times—along with growing adoption in sports medicine and post-surgical care further drives demand. Regulatory support for safer pain management alternatives and expanding over-the-counter availability also contribute to market growth, though challenges include skin irritation risks and competition from oral and topical alternatives. Geographically, North America and Europe dominate due to high healthcare spending and awareness, while Asia-Pacific shows rapid growth fueled by increasing healthcare access and chronic pain prevalence.
The global Non opioid Pain Patches market size was estimated at USD 683.21 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 2.63% during the forecast period.
This report provides a deep insight into the global Non opioid Pain Patches market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non opioid Pain Patches Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non opioid Pain Patches market in any manner.
Global Non opioid Pain Patches Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
GlaxoSmithKline
Johnson and Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
Market Segmentation (by Type)
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Market Segmentation (by Application)
Hospital Pharmacies
Independent Pharmacies and Drug Stores
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Non opioid Pain Patches Market
Overview of the regional outlook of the Non opioid Pain Patches Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non opioid Pain Patches Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non opioid Pain Patches, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Non-opioid pain patches are transdermal therapeutic systems designed to deliver analgesic medications—such as lidocaine, diclofenac, capsaicin, or methyl salicylate—through the skin to provide localized or systemic pain relief without the risks associated with opioid use, including addiction and systemic side effects. These patches are widely used for chronic pain conditions like arthritis, neuropathy, and musculoskeletal injuries, offering controlled drug release for extended periods while minimizing gastrointestinal and hepatic side effects common with oral analgesics. The market has expanded due to rising opioid misuse concerns, an aging population with higher pain management needs, and increasing preference for non-invasive, targeted drug delivery. Innovation in patch formulations—such as combination therapies and longer wear times—along with growing adoption in sports medicine and post-surgical care further drives demand. Regulatory support for safer pain management alternatives and expanding over-the-counter availability also contribute to market growth, though challenges include skin irritation risks and competition from oral and topical alternatives. Geographically, North America and Europe dominate due to high healthcare spending and awareness, while Asia-Pacific shows rapid growth fueled by increasing healthcare access and chronic pain prevalence.
The global Non opioid Pain Patches market size was estimated at USD 683.21 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 2.63% during the forecast period.
This report provides a deep insight into the global Non opioid Pain Patches market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non opioid Pain Patches Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non opioid Pain Patches market in any manner.
Global Non opioid Pain Patches Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
GlaxoSmithKline
Johnson and Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
Market Segmentation (by Type)
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Market Segmentation (by Application)
Hospital Pharmacies
Independent Pharmacies and Drug Stores
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Non opioid Pain Patches Market
Overview of the regional outlook of the Non opioid Pain Patches Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non opioid Pain Patches Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non opioid Pain Patches, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
149 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Non Opioid Pain Patches
- 1.2 Key Market Segments
- 1.2.1 Non Opioid Pain Patches Segment By Type
- 1.2.2 Non Opioid Pain Patches Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Non Opioid Pain Patches Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Non Opioid Pain Patches Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Non Opioid Pain Patches Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Non Opioid Pain Patches Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Non Opioid Pain Patches Product Life Cycle
- 3.3 Global Non Opioid Pain Patches Sales By Manufacturers (2020-2025)
- 3.4 Global Non Opioid Pain Patches Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Non Opioid Pain Patches Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Non Opioid Pain Patches Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Non Opioid Pain Patches Market Competitive Situation And Trends
- 3.8.1 Non Opioid Pain Patches Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Non Opioid Pain Patches Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Non Opioid Pain Patches Industry Chain Analysis
- 4.1 Non Opioid Pain Patches Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Non Opioid Pain Patches Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Non Opioid Pain Patches Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Non Opioid Pain Patches Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Non Opioid Pain Patches Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Non Opioid Pain Patches Sales Market Share By Type (2020-2025)
- 6.3 Global Non Opioid Pain Patches Market Size Market Share By Type (2020-2025)
- 6.4 Global Non Opioid Pain Patches Price By Type (2020-2025)
- 7 Non Opioid Pain Patches Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Non Opioid Pain Patches Market Sales By Application (2020-2025)
- 7.3 Global Non Opioid Pain Patches Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Non Opioid Pain Patches Sales Growth Rate By Application (2020-2025)
- 8 Non Opioid Pain Patches Market Sales By Region
- 8.1 Global Non Opioid Pain Patches Sales By Region
- 8.1.1 Global Non Opioid Pain Patches Sales By Region
- 8.1.2 Global Non Opioid Pain Patches Sales Market Share By Region
- 8.2 Global Non Opioid Pain Patches Market Size By Region
- 8.2.1 Global Non Opioid Pain Patches Market Size By Region
- 8.2.2 Global Non Opioid Pain Patches Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Non Opioid Pain Patches Sales By Country
- 8.3.2 North America Non Opioid Pain Patches Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Non Opioid Pain Patches Sales By Country
- 8.4.2 Europe Non Opioid Pain Patches Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Non Opioid Pain Patches Sales By Region
- 8.5.2 Asia Pacific Non Opioid Pain Patches Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Non Opioid Pain Patches Sales By Country
- 8.6.2 South America Non Opioid Pain Patches Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Non Opioid Pain Patches Sales By Region
- 8.7.2 Middle East And Africa Non Opioid Pain Patches Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Non Opioid Pain Patches Market Production By Region
- 9.1 Global Production Of Non Opioid Pain Patches By Region(2020-2025)
- 9.2 Global Non Opioid Pain Patches Revenue Market Share By Region (2020-2025)
- 9.3 Global Non Opioid Pain Patches Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Non Opioid Pain Patches Production
- 9.4.1 North America Non Opioid Pain Patches Production Growth Rate (2020-2025)
- 9.4.2 North America Non Opioid Pain Patches Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Non Opioid Pain Patches Production
- 9.5.1 Europe Non Opioid Pain Patches Production Growth Rate (2020-2025)
- 9.5.2 Europe Non Opioid Pain Patches Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Non Opioid Pain Patches Production (2020-2025)
- 9.6.1 Japan Non Opioid Pain Patches Production Growth Rate (2020-2025)
- 9.6.2 Japan Non Opioid Pain Patches Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Non Opioid Pain Patches Production (2020-2025)
- 9.7.1 China Non Opioid Pain Patches Production Growth Rate (2020-2025)
- 9.7.2 China Non Opioid Pain Patches Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Pfizer
- 10.1.1 Pfizer Basic Information
- 10.1.2 Pfizer Non Opioid Pain Patches Product Overview
- 10.1.3 Pfizer Non Opioid Pain Patches Product Market Performance
- 10.1.4 Pfizer Business Overview
- 10.1.5 Pfizer Swot Analysis
- 10.1.6 Pfizer Recent Developments
- 10.2 Glaxosmithkline
- 10.2.1 Glaxosmithkline Basic Information
- 10.2.2 Glaxosmithkline Non Opioid Pain Patches Product Overview
- 10.2.3 Glaxosmithkline Non Opioid Pain Patches Product Market Performance
- 10.2.4 Glaxosmithkline Business Overview
- 10.2.5 Glaxosmithkline Swot Analysis
- 10.2.6 Glaxosmithkline Recent Developments
- 10.3 Johnson And Johnson
- 10.3.1 Johnson And Johnson Basic Information
- 10.3.2 Johnson And Johnson Non Opioid Pain Patches Product Overview
- 10.3.3 Johnson And Johnson Non Opioid Pain Patches Product Market Performance
- 10.3.4 Johnson And Johnson Business Overview
- 10.3.5 Johnson And Johnson Swot Analysis
- 10.3.6 Johnson And Johnson Recent Developments
- 10.4 Novartis Ag
- 10.4.1 Novartis Ag Basic Information
- 10.4.2 Novartis Ag Non Opioid Pain Patches Product Overview
- 10.4.3 Novartis Ag Non Opioid Pain Patches Product Market Performance
- 10.4.4 Novartis Ag Business Overview
- 10.4.5 Novartis Ag Recent Developments
- 10.5 Mylan N.V.
- 10.5.1 Mylan N.V. Basic Information
- 10.5.2 Mylan N.V. Non Opioid Pain Patches Product Overview
- 10.5.3 Mylan N.V. Non Opioid Pain Patches Product Market Performance
- 10.5.4 Mylan N.V. Business Overview
- 10.5.5 Mylan N.V. Recent Developments
- 10.6 Teva Pharmaceutical Industries
- 10.6.1 Teva Pharmaceutical Industries Basic Information
- 10.6.2 Teva Pharmaceutical Industries Non Opioid Pain Patches Product Overview
- 10.6.3 Teva Pharmaceutical Industries Non Opioid Pain Patches Product Market Performance
- 10.6.4 Teva Pharmaceutical Industries Business Overview
- 10.6.5 Teva Pharmaceutical Industries Recent Developments
- 10.7 Hisamitsu Pharmaceutical
- 10.7.1 Hisamitsu Pharmaceutical Basic Information
- 10.7.2 Hisamitsu Pharmaceutical Non Opioid Pain Patches Product Overview
- 10.7.3 Hisamitsu Pharmaceutical Non Opioid Pain Patches Product Market Performance
- 10.7.4 Hisamitsu Pharmaceutical Business Overview
- 10.7.5 Hisamitsu Pharmaceutical Recent Developments
- 10.8 Teh Seng Pharmaceutical
- 10.8.1 Teh Seng Pharmaceutical Basic Information
- 10.8.2 Teh Seng Pharmaceutical Non Opioid Pain Patches Product Overview
- 10.8.3 Teh Seng Pharmaceutical Non Opioid Pain Patches Product Market Performance
- 10.8.4 Teh Seng Pharmaceutical Business Overview
- 10.8.5 Teh Seng Pharmaceutical Recent Developments
- 10.9 Teikoku Seiyaku
- 10.9.1 Teikoku Seiyaku Basic Information
- 10.9.2 Teikoku Seiyaku Non Opioid Pain Patches Product Overview
- 10.9.3 Teikoku Seiyaku Non Opioid Pain Patches Product Market Performance
- 10.9.4 Teikoku Seiyaku Business Overview
- 10.9.5 Teikoku Seiyaku Recent Developments
- 10.10 Ibsa Institut Biochimque Sa
- 10.10.1 Ibsa Institut Biochimque Sa Basic Information
- 10.10.2 Ibsa Institut Biochimque Sa Non Opioid Pain Patches Product Overview
- 10.10.3 Ibsa Institut Biochimque Sa Non Opioid Pain Patches Product Market Performance
- 10.10.4 Ibsa Institut Biochimque Sa Business Overview
- 10.10.5 Ibsa Institut Biochimque Sa Recent Developments
- 10.11 Acorda Therapeutics
- 10.11.1 Acorda Therapeutics Basic Information
- 10.11.2 Acorda Therapeutics Non Opioid Pain Patches Product Overview
- 10.11.3 Acorda Therapeutics Non Opioid Pain Patches Product Market Performance
- 10.11.4 Acorda Therapeutics Business Overview
- 10.11.5 Acorda Therapeutics Recent Developments
- 10.12 Allergan Plc
- 10.12.1 Allergan Plc Basic Information
- 10.12.2 Allergan Plc Non Opioid Pain Patches Product Overview
- 10.12.3 Allergan Plc Non Opioid Pain Patches Product Market Performance
- 10.12.4 Allergan Plc Business Overview
- 10.12.5 Allergan Plc Recent Developments
- 10.13 Endo International
- 10.13.1 Endo International Basic Information
- 10.13.2 Endo International Non Opioid Pain Patches Product Overview
- 10.13.3 Endo International Non Opioid Pain Patches Product Market Performance
- 10.13.4 Endo International Business Overview
- 10.13.5 Endo International Recent Developments
- 11 Non Opioid Pain Patches Market Forecast By Region
- 11.1 Global Non Opioid Pain Patches Market Size Forecast
- 11.2 Global Non Opioid Pain Patches Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Non Opioid Pain Patches Market Size Forecast By Country
- 11.2.3 Asia Pacific Non Opioid Pain Patches Market Size Forecast By Region
- 11.2.4 South America Non Opioid Pain Patches Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Non Opioid Pain Patches By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Non Opioid Pain Patches Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Non Opioid Pain Patches By Type (2026-2033)
- 12.1.2 Global Non Opioid Pain Patches Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Non Opioid Pain Patches By Type (2026-2033)
- 12.2 Global Non Opioid Pain Patches Market Forecast By Application (2026-2033)
- 12.2.1 Global Non Opioid Pain Patches Sales (K Mt) Forecast By Application
- 12.2.2 Global Non Opioid Pain Patches Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.